New Drug Candidates for Breast Cancer Treatment
Author Information
Author(s): Lalagkas Panagiotis N., Melamed Rachel D.
Primary Institution: Department of Biological Sciences, University of Massachusetts, Lowell, MA USA
Hypothesis
If a predisposing disease contributes to breast cancer pathology, identifying the pleiotropic genes related to the risk of cancer could prioritize drugs treating that disease.
Conclusion
The study identifies 59 novel candidate drugs for breast cancer treatment based on shared genetics with predisposing diseases.
Supporting Evidence
- 84 loci harboring mutations were identified with positively correlated effects between breast cancer and its predisposing diseases.
- Out of 112 drugs indicated for the predisposing diseases, 74 can be linked to shared genes via pathways.
- 15 candidate drugs are already in advanced clinical trial phases or approved for breast cancer.
Takeaway
The researchers found new drugs that might help treat breast cancer by looking at genes shared with other diseases that increase breast cancer risk.
Methodology
The study used GWAS summary statistics to identify shared genes and linked them to drugs treating predisposing diseases through canonical pathways.
Potential Biases
Potential bias due to reliance on high-confidence edges in the STRING PPI network.
Limitations
The study relies on GWAS data from European populations, which may miss shared loci in other populations.
Participant Demographics
The study primarily analyzed data from individuals of European ancestry.
Statistical Information
P-Value
7.99e-03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website